Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma (GBM) progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation. “Classical wisdom is that brain tumor progression is linked to oncogene activation and tumor suppressor gene inactivation; however genetic and epigenetic mutations are not the only cause of GBM progression,” said Shulin Li, Ph.D. “Some immune regulators can do the...

A large nationwide study led by The University of Texas Medical Branch at Galveston has confirmed that among various surgical procedures, removing sections of the colon carries the highest risk of complications and has a 46 percent mortality rate, despite efforts to improve surgical outcomes at large. Shining light on this issue can guide advances and improvements targeted directly toward this procedure. The American College of Surgeons works to improve the quality of surgeries throughout...

There is a new medication that in one dose successfully protected nonhuman primates against a lethal infection of all strains of the deadly Ebola virus. Dr. Thomas Geisbert, a world-renowned Ebola researcher at The University of Texas Medical Branch at Galveston, said that previous therapeutics typically were of the “one bug, one drug” variety. But because of the unpredictable nature and variety of the Ebola virus, scientists have been seeking a way to protect against...